Leap Therapeutics Inc (LPTX) stock has gained 56.85% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives LPTX stock a score of 71 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 100. LPTX's rank also includes a fundamental score of 58. In addition to the average rating from Wall Street analysts, LPTX stock has a mean target price of $4.25. This means analysts expect the stock to climb 37.54% over the next 12 months. The short-term technical score for LPTX is 55.
LPTX has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on LPTX!
Leap Therapeutics Inc (LPTX) stock has risen 11.59% while the S&P 500 has gained 0.22% as of 10:26 AM on Tuesday, Sep 21. LPTX has gained $0.32 from the previous closing price of $2.77 on volume of 3,461,746 shares. Over the past year the S&P 500 has risen 33.10% while LPTX has gained 56.85%. LPTX lost -$0.52 per share in the over the last 12 months.
Click Here to get the full Stock Report for Leap Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
